Lilly breast cancer drug results could challenge Pfizer pill
Eli Lilly and Co.' s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.
from Biotech News
0 Comments